The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Co-Diovan 160 mg/25 mg film-coated tablets

160 mg/25 milligram(s) Film-coated tablet

Novartis Ireland LimitedPA0896/007/003

Main Information

Trade NameCo-Diovan 160 mg/25 mg film-coated tablets
Active SubstancesValsartan
Hydrochlorothiazide
Strength160 mg/25 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderNovartis Ireland Limited
Licence NumberPA0896/007/003

Group Information

ATC CodeC09DA Angiotensin II antagonists and diuretics
C09DA03 valsartan and diuretics

Status

Authorised/WithdrawnAuthorised
Licence Issued03/12/2004
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0040-078-003
Interchangeable List DocumentPDF of Interchangeable List
« Back